RXO (NYSE:RXO – Free Report) had its price objective trimmed by Susquehanna from $20.00 to $16.00 in a research report sent to investors on Thursday morning, Benzinga reports. The brokerage currently has a negative rating on the stock.
Other research analysts have also recently issued research reports about the stock. Barclays upped their target price on shares of RXO from $24.00 to $30.00 and gave the company an overweight rating in a research report on Tuesday, July 16th. JPMorgan Chase & Co. upped their target price on shares of RXO from $25.00 to $26.00 and gave the company an underweight rating in a research report on Thursday, August 8th. TD Cowen upped their target price on shares of RXO from $23.00 to $28.00 and gave the company a hold rating in a research report on Thursday, August 8th. Oppenheimer reaffirmed an outperform rating and issued a $31.00 target price on shares of RXO in a research report on Tuesday, September 17th. Finally, Morgan Stanley increased their price target on shares of RXO from $19.00 to $26.00 and gave the stock an equal weight rating in a research report on Monday, August 12th. Two research analysts have rated the stock with a sell rating, nine have issued a hold rating and three have assigned a buy rating to the company. According to MarketBeat, the company has a consensus rating of Hold and an average price target of $25.67.
Read Our Latest Analysis on RXO
RXO Trading Up 1.0 %
RXO (NYSE:RXO – Get Free Report) last announced its quarterly earnings results on Wednesday, August 7th. The company reported $0.03 earnings per share for the quarter, meeting the consensus estimate of $0.03. The firm had revenue of $930.00 million for the quarter, compared to analysts’ expectations of $934.14 million. RXO had a negative net margin of 0.55% and a positive return on equity of 2.22%. The company’s revenue was down 3.4% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.08 EPS. As a group, equities analysts predict that RXO will post 0.14 earnings per share for the current year.
Institutional Trading of RXO
A number of large investors have recently made changes to their positions in the company. MFN Partners Management LP increased its stake in RXO by 11.0% in the second quarter. MFN Partners Management LP now owns 17,310,856 shares of the company’s stock valued at $452,679,000 after purchasing an additional 1,722,301 shares during the last quarter. Vanguard Group Inc. increased its stake in RXO by 0.3% in the first quarter. Vanguard Group Inc. now owns 13,294,483 shares of the company’s stock valued at $290,750,000 after purchasing an additional 45,977 shares during the last quarter. Swedbank AB purchased a new position in RXO in the first quarter valued at approximately $76,982,000. Douglas Lane & Associates LLC increased its stake in RXO by 2.0% in the second quarter. Douglas Lane & Associates LLC now owns 2,698,525 shares of the company’s stock valued at $70,566,000 after purchasing an additional 52,378 shares during the last quarter. Finally, Dimensional Fund Advisors LP increased its stake in RXO by 9.5% in the second quarter. Dimensional Fund Advisors LP now owns 2,032,929 shares of the company’s stock valued at $53,153,000 after purchasing an additional 176,041 shares during the last quarter. 92.73% of the stock is currently owned by hedge funds and other institutional investors.
RXO Company Profile
RXO, Inc provides full truckload freight transportation brokering services. It also offers brokered services for managed transportation, last mile, and freight forwarding. The company was incorporated in 2022 and is based in Charlotte, North Carolina.
Featured Stories
- Five stocks we like better than RXO
- Stock Splits, Do They Really Impact Investors?
- CarMax’s Impressive Rally: What Investors Should Watch Next
- Breakout Stocks: What They Are and How to Identify Them
- MarketBeat Week in Review – 9/23 – 9/27
- What is the FTSE 100 index?
- Wake Up to This Biotech Stock That Still Has Big Potential Upside
Receive News & Ratings for RXO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RXO and related companies with MarketBeat.com's FREE daily email newsletter.